---

---

symbols : NVS    crawled time : 15:00   

save search

---

Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published: 2024-03-25 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -2.86% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -3.27% | O: -0.08% H: 0.15% C: -0.44%
LLY | News | $749.245 -0.2% 550K |

Health Technology

| -2.57% | O: 0.06% H: 0.96% C: 0.26%
CAH | $106.87 0.33% 220K |

Distribution Services

| -3.46% | O: 0.02% H: 0.73% C: -0.02%
LNTH | $63.36 3.06% 620K |

Health Technology

| 4.17% | O: 0.1% H: 1.98% C: -0.08%
reach cancer treatment market

---

Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
ENDPQ | $0.0006 620K |

n/a

| 60.0% | O: -20.0% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -3.34% | O: -1.29% H: 0.4% C: 0.4%
PPCB | $0.0014 4.4M |

Manufacturing

| -88.7% | O: 0.0% H: 2.61% C: -4.35%
PFE A | $25.325 -0.37% 15M |

Health Technology

| -11.21% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -2.97% | O: 0.19% H: 0.35% C: 0.2%
active market

---

Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
Published: 2023-11-24 (Crawled : 15:00) - prnewswire.com
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -4.13% | O: 0.89% H: 0.39% C: 0.19%
sandimmune solution novartis 100

---

T-cell Therapy Market Size to Grow USD US$ 76.6 billion from 2023-2033 | Says Transparency Market Research Inc.
Published: 2023-11-06 (Crawled : 15:00) - prnewswire.com
NVS | News | $92.61 -0.51% 430K |

Health Technology

| 0.34% | O: 0.54% H: 0.73% C: 0.2%
t-cell research therapy market

---

Global Sustained Release Excipients Markets, 2017-2022, 2022-2027F, 2032F: Escalating Demand for Advanced Drug Formulations, Fueled by Higher Prevalence of Chronic and Acute Diseases
Published: 2023-09-29 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 510 |

Health Technology

| 10.65% | O: -0.03% H: 0.0% C: -1.26%
AZNCF | $140.15 560 |

Health Technology

| -0.62% | O: 0.66% H: 0.0% C: -1.46%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -9.04% | O: 1.18% H: 0.06% C: -1.62%
GSK | $39.44 -0.4% 560K |

Health Technology

| 8.97% | O: 0.52% H: 0.37% C: -0.77%
AZN | $68.635 0.15% 1.3M |

Health Technology

| 1.25% | O: 2.02% H: 0.0% C: -1.54%
drug global

---

RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| -14.44% | O: 1.53% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 10.49% | O: 0.79% H: 0.0% C: 0.0%
ALPMY | News | $9.46 500K |

Manufacturing

| -37.69% | O: 3.0% H: 0.0% C: -3.43%
PFE A | $25.325 -0.37% 15M |

Health Technology

| -25.56% | O: -0.26% H: 1.04% C: 0.03%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -8.59% | O: 1.51% H: 0.26% C: -0.72%
SRPT | $118.32 0.37% 65K |

Health Technology

| -1.53% | O: -0.27% H: 0.54% C: -0.84%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -15.47% | O: 0.82% H: 0.0% C: 0.0%
MRNA | News S | $101.87 -1.52% 710K |

Health Technology

| -8.31% | O: 0.16% H: 2.0% C: 1.42%
IONS | $41.14 0.56% 210K |

Health Technology

| -6.26% | O: -0.57% H: 0.35% C: -1.11%
BNTX | $86.085 -0.37% 160K |

Health Technology

| -24.14% | O: 0.17% H: 0.48% C: -0.82%
ARWR | $22.33 -0.89% 170K |

Health Technology

| -22.5% | O: 0.16% H: 0.46% C: -5.46%
ALNY | $146.09 0.53% 59K |

Health Technology

| -24.0% | O: -0.74% H: 2.42% C: -3.47%
therapeutics market

---

Global Plant Based API Market Analysis Report 2023-2028: Many Pharmaceutical Companies are Now Developing Plant-based APIs to Meet Demand
Published: 2023-08-28 (Crawled : 15:00) - prnewswire.com
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -8.55% | O: 1.06% H: 0.06% C: -0.51%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -13.68% | O: 0.73% H: 0.0% C: 0.0%
companies report global market

---

Viral Vector Manufacturing Market worth $12.8 billion | MarketsandMarkets
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
LZAGF | $579.0 49 |

Health Technology

| -5.7% | O: 3.47% H: 0.0% C: -2.56%
LZAGY | $57.3 33K |

Professional, Scientific, and T...

| -8.17% | O: -0.59% H: 0.02% C: 0.02%
TMO | News | $542.43 -0.88% 810K |

Health Technology

| 5.61% | O: 0.35% H: 0.91% C: 0.71%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -7.78% | O: -0.16% H: 0.11% C: -0.76%
DHR | $237.72 -0.7% 1.4M |

Health Technology

| 2.11% | O: 0.0% H: 1.29% C: 1.14%
CRL | $231.13 0.45% 240K |

Commercial Services

| 17.53% | O: 0.08% H: 5.1% C: 3.86%
BLUE | $0.9616 -0.18% 1.9M |

Health Technology

| -72.87% | O: 1.37% H: 0.29% C: -5.41%
market

---

Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
ALPMY | News | $9.46 500K |

Manufacturing

| -42.42% | O: -0.68% H: 3.23% C: 1.55%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -7.78% | O: -0.16% H: 0.11% C: -0.76%
ORTX | $16.7 0.0% 370K |

Health Technology

| 241.48% | O: 0.62% H: 4.57% C: 2.04%
GBIO | $2.89 -3.02% 45K |

Health Technology

| -38.43% | O: 0.0% H: 11.57% C: 6.4%
BIIB | $191.72 -0.23% 370K |

Health Technology

| -36.82% | O: 3.52% H: 0.0% C: -1.99%
AMGN | $265.48 0.53% 360K |

Health Technology

| 22.02% | O: 0.22% H: 0.0% C: -0.86%
ADAP | $0.9089 -7.91% 740K |

Health Technology

| 4.31% | O: -0.75% H: 7.14% C: 6.12%
ABEO | $7.585 -4.35% 97K |

Health Technology

| 82.59% | O: 0.0% H: 4.4% C: 3.29%
drug set therapy growth market

---

DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain
Published: 2023-05-23 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 10.85% | O: -1.22% H: 0.0% C: -0.62%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -7.6% | O: 0.74% H: 0.0% C: -1.22%
GKOS M | $96.89 32K |

Health Technology

| 63.39% | O: -0.71% H: 2.06% C: -1.05%
BHC | $8.735 0.87% 570K |

Health Technology

| -0.68% | O: -2.27% H: 4.24% C: -2.21%
ALC | $79.03 0.04% 230K |

Health Technology

| -2.58% | O: -0.51% H: 0.02% C: -3.25%
ABBV | $167.2 1.8% 1.3M |

Health Technology

| 13.13% | O: -0.31% H: 0.26% C: -1.34%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -15.16% | O: -0.01% H: 0.0% C: 0.0%
OCUL | $6.6 -12.93% 2.6M |

Health Technology

| 16.44% | O: 4.45% H: 7.65% C: 2.21%
GRFS | $6.59 0.15% 350K |

Health Technology

| -26.97% | O: 0.78% H: 0.0% C: -3.74%
ALDX 4 | $4.06 2.27% 98K |

Health Technology

| -60.35% | O: 0.0% H: 2.36% C: 0.61%
pharma disease pipeline set eye trial

---

Global Pancreatic Cancer Competitive Landscape Report 2023: Comprehensive Insights about 250+ Companies and 300+ Drugs
Published: 2023-05-08 (Crawled : 15:00) - prnewswire.com
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -11.12% | O: -0.11% H: 0.72% C: 0.3%
TCRR 4 | $1.48 3.38% 3.9M |

Health Technology

| -21.28% | O: 6.91% H: 1.49% C: -2.49%
INCY | $52.46 -0.49% 330K |

Health Technology

| -20.79% | O: 0.03% H: 0.17% C: -1.19%
BNTX | $86.085 -0.37% 160K |

Health Technology

| -20.37% | O: 4.23% H: 0.0% C: -4.4%
ADAP | $0.9089 -7.91% 740K |

Health Technology

| -26.43% | O: 1.43% H: 2.11% C: -1.41%
companies report cancer pancreatic global

---

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Published: 2023-04-26 (Crawled : 15:00) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 7.63% | O: 0.0% H: 0.0% C: 0.0%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -10.53% | O: 0.62% H: 0.0% C: -2.04%
breast asco cancer kisqali novartis trial

---

Erasca Announces Publication of Promising Clinical Data Supporting the Therapeutic Potential of Naporafenib in Combination with Trametinib in NRAS-Mutant Melanoma
Published: 2023-04-25 (Crawled : 15:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 12.37% | O: 5.0% H: 0.0% C: -0.57%
ERAS | $1.85 0.54% 170K |

| -28.52% | O: 0.0% H: 2.59% C: -3.7%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -7.47% | O: 4.24% H: 0.68% C: -0.77%
melanoma publication potential

---

Gallbladder Cancer Therapeutics Market size to grow by USD 103.57 million from 2021 to 2026, Driven by the strong incidence of gallbladder cancer in developing countries - Technavio
Published: 2023-04-12 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| -15.5% | O: 3.22% H: 0.01% C: 0.01%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 17.97% | O: 1.1% H: 0.0% C: 0.0%
ALPMY | News | $9.46 500K |

Manufacturing

| -33.52% | O: 1.92% H: 0.77% C: 0.56%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -2.84% | O: 0.75% H: 0.5% C: -0.05%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -17.16% | O: 0.47% H: 0.0% C: 0.0%
cancer therapeutics market

---

Motion Sickness Treatment Market to Reach $525 Million, Globally, by 2031 at 2.9% CAGR: Allied Market Research
Published: 2023-03-28 (Crawled : 15:00) - prnewswire.com
VTRS | $11.22 1.08% 510K |

Health Technology

| 17.21% | O: -0.42% H: 1.06% C: 1.06%
TEVA | $13.09 -0.68% 990K |

Health Technology

| 50.97% | O: -0.46% H: 1.84% C: 0.81%
PBH | $68.52 0.72% 22K |

Health Technology

| 8.94% | O: -0.5% H: 1.17% C: 0.84%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| 3.1% | O: -0.38% H: 1.25% C: 1.12%
BAX | News | $39.56 0.1% 520K |

Health Technology

| -0.92% | O: -0.45% H: 0.83% C: -0.1%
ABT | News | $105.52 -0.36% 1.6M |

Health Technology

| 9.62% | O: -0.37% H: 0.14% C: -1.01%
treatment research market

---

Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation
Published: 2023-03-21 (Crawled : 15:00) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 36.78% | O: 1.89% H: 0.0% C: -1.15%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| 11.57% | O: 0.25% H: 0.19% C: 0.04%
hyrimoz fda biosimilar approval

---

High Adoption Rate Of A New Treatment Against Cancer is likely to proliferate the Neuroendocrine Tumor Treatment CAGR: 10%|UnivDatos Market Insights
Published: 2023-02-03 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 30.54% | O: -0.09% H: 0.0% C: -0.45%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| 8.11% | O: -0.02% H: 0.71% C: -0.27%
ABBV | $167.2 1.8% 1.3M |

Health Technology

| 13.18% | O: 0.75% H: 0.6% C: -0.49%
treatment tumor cancer market

---

Global Active Pharmaceutical Ingredients (APIs) Market Report, 2022 & 2023-2027: Biotech APIs Used in Biologics are Increasingly Becoming the Top-Selling Drugs in the Market
Published: 2023-01-16 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 510 |

Health Technology

| Email alert Add to watchlist
NVS | News | $92.61 -0.51% 430K |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
SNY | News | $45.56 -1.19% 910K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 1.4K |

Health Technology

| Email alert Add to watchlist
GSK | $39.44 -0.4% 560K |

Health Technology

| Email alert Add to watchlist
global active biotech market

---

Global Spinal Muscular Atrophy Treatment Market Report 2022: Sector to Reach $11.4 Billion by 2028 at a 17.8% CAGR
Published: 2023-01-09 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 24.84% | O: 3.12% H: 0.0% C: -2.55%
PFE A | $25.325 -0.37% 15M |

Health Technology

| -50.08% | O: -1.71% H: 0.42% C: -3.32%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| 0.86% | O: 0.76% H: 0.26% C: -3.27%
BHVN | News 0 d | $41.69 -5.32% 1.6M |

Health Technology

| 203.95% | O: 0.35% H: 9.67% C: 3.25%
SRRK A | $13.835 0.99% 62K |

Health Technology

| 46.37% | O: 1.5% H: 2.42% C: -0.11%
PTCT | News | $25.02 -0.56% 170K |

Health Technology

| -36.03% | O: 0.1% H: 10.44% C: 5.66%
IONS | $41.14 0.56% 210K |

Health Technology

| 0.96% | O: -0.17% H: 0.84% C: -7.91%
treatment global report market muscular atrophy

---

Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 510 |

Health Technology

| 16.83% | O: 1.13% H: 0.0% C: 0.0%
SNYNF | News | $92.7 1.4K |

Health Technology

| -3.69% | O: 0.77% H: 0.0% C: -0.74%
AZNCF | $140.15 560 |

Health Technology

| 0.14% | O: 1.08% H: 0.0% C: -0.25%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| 1.62% | O: -0.01% H: 0.08% C: -0.95%
GSK | $39.44 -0.4% 560K |

Health Technology

| 12.72% | O: -0.37% H: 0.89% C: 0.4%
SNY | News | $45.56 -1.19% 910K |

Health Technology

| -5.03% | O: -0.39% H: 0.0% C: 0.0%
AZN | $68.635 0.15% 1.3M |

Health Technology

| 0.24% | O: -0.46% H: 0.38% C: 0.01%
global report sanofi market

---

Gainers vs Losers

82%

18%

Top 10 Gainers

AGBA | $0.7995 99.88% 73M |

Finance

BPTH | $6.21 91.67% 58M |

Health Technology

INVO | $1.36 78.95% 3.6M |

Health Technology

TIRX | $0.8258 70.34% 50M |

ISPC | $0.307 44.13% 3.6M |

Professional, Scientific, and T...

SINT | $0.0519 39.14% 350M |

Health Technology

VTNR S | $1.295 32.25% 5.5M |

Industrial Services

ALRN | $5.53 30.12% 250K |

Health Technology

SMSI 4 | $2.53 29.74% 510K |

Technology Services

HOLO | $2.86 27.68% 28M |

---

Your saved searches

---